Lifecore Biomedical, Inc. (LFCR) vs Organigram Global Inc. (OGI)
Lifecore Biomedical, Inc. and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. and Organigram Global Inc. are of similar size ($162.4M and $155.1M). Lifecore Biomedical, Inc. has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.4×. Organigram Global Inc. grew revenue faster over the last twelve months: 39.5% against −10.0%. Organigram Global Inc. has the higher net margin (28.4% vs −37.5%) and the higher return on invested capital (−1.53% vs −2.80%). Across the 17 metrics below, Organigram Global Inc. leads on 13 and Lifecore Biomedical, Inc. on 4.
Valuation
Profitability
| Metric | LFCR | OGI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 26.86% | 36.47% | 53.94% |
| Operating margin | (6.89%) | (3.91%) | 0.00% |
| Net margin | (37.54%) | 28.44% | 0.00% |
| Free cash flow margin | (4.24%) | (9.46%) | 0.00% |
| Return on equity | 201.15% | 20.20% | (0.40%) |
| Return on assets | (19.32%) | 12.70% | (3.32%) |
| Return on invested capital | (2.80%) | (1.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack